1. Home
  2. EU vs TMCI Comparison

EU vs TMCI Comparison

Compare EU & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo enCore Energy Corp.

EU

enCore Energy Corp.

HOLD

Current Price

$1.24

Market Cap

306.9M

ML Signal

HOLD

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

HOLD

Current Price

$4.68

Market Cap

279.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EU
TMCI
Founded
2009
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
306.9M
279.6M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
EU
TMCI
Price
$1.24
$4.68
Analyst Decision
Strong Buy
Hold
Analyst Count
1
6
Target Price
$4.00
$4.77
AVG Volume (30 Days)
2.9M
393.4K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
11.76
N/A
EPS
0.03
N/A
Revenue
$43,155,000.00
$212,690,000.00
Revenue This Year
$212.11
N/A
Revenue Next Year
$29.88
$8.18
P/E Ratio
$41.00
N/A
Revenue Growth
N/A
1.59
52 Week Low
$1.03
$1.17
52 Week High
$4.19
$7.78

Technical Indicators

Market Signals
Indicator
EU
TMCI
Relative Strength Index (RSI) 42.29 52.55
Support Level N/A $3.84
Resistance Level $1.79 $4.67
Average True Range (ATR) 0.07 0.28
MACD 0.01 0.02
Stochastic Oscillator 47.83 52.48

Price Performance

Historical Comparison
EU
TMCI

About EU enCore Energy Corp.

enCore Energy Corp together with its subsidiary, is principally engaged in the acquisition, exploration, development and extraction of uranium resource properties in the United States. The Company is focused on the extraction of domestic uranium in the United States. The Company utilizes the In-Situ Recovery technology (ISR) to provide necessary fuel for the generation of clean, reliable, and carbon-free nuclear energy.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.

Share on Social Networks: